| Bioactivity | C22 Galactosylceramide-d4 is deuterium labeled C22 Galactosylceramide. C22 Galactosylceramide is a sphingolipid present in the central nervous system, exhibiting elevated levels in the spinal cord of mice on a methionine-restricted diet, while not affecting the brain or liver; furthermore, it has been identified in the postmortem hippocampus of Alzheimer's disease patients[1]. |
| CAS | 2750534-73-5 |
| Formula | C46H85D4NO8 |
| Molar Mass | 788.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
C22 Galactosylceramide-d4
CAS: 2750534-73-5 F: C46H85D4NO8 W: 788.23
C22 Galactosylceramide-d4 is deuterium labeled C22 Galactosylceramide. C22 Galactosylceramide is a sphingolipid present
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.